« Later Stage Treatment »

A Melanoma Vaccine for Metastatic Patients

Dr. Cecilia Larocca Dana-Farber Cancer Institute

There’s only one vaccine that has been approved by the Food and Drug Administration for the treatment of metastatic melanoma patients. Talimogene Laherparepvec (T-VEC) is a modified herpes virus that’s injected directly into the lesion and causes the death of cancer cells. It is approved for melanoma that cannot be surgically removed. There have been a number of studies of other potential melanoma treatments, but so far none have been successful.

Additionally, both targeted therapies and immunotherapy have been very successful in treating stage four disease.

Learn more about SurvivorNet's rigorous medical review process.

Dr. Cecilia Larocca is a dermatologist at Dana-Farber Cancer Institute. Read More

Later Stage Melanoma

There have been many developments in recent years when it comes to treating melanoma, but there is no one-size-fits-all approach to this disease. Doctors have a handful of tools to choose from, and many factors will go into determining your treatment.